ATXS |
Astria Therapeutics, Inc. |
Jun 5, 2024 |
1 |
$0 |
4 |
Jun 6, 2024 |
Director |
DNTH |
Dianthus Therapeutics, Inc. /DE/ |
May 23, 2024 |
1 |
$0 |
4 |
May 28, 2024 |
Director |
MGTA |
Dianthus Therapeutics, Inc. /DE/ |
Sep 11, 2023 |
1 |
$0 |
4 |
Sep 13, 2023 |
Director |
MGTA |
Dianthus Therapeutics, Inc. /DE/ |
Sep 11, 2023 |
0 |
$0 |
3 |
Sep 13, 2023 |
Director |
ATXS |
Astria Therapeutics, Inc. |
Jun 2, 2023 |
1 |
$0 |
4 |
Jun 6, 2023 |
Director |
VRDN |
Viridian Therapeutics, Inc.\DE |
Feb 2, 2023 |
3 |
-$1.83M |
4/A |
Feb 7, 2023 |
Chief Executive Officer, Director |
VRDN |
Viridian Therapeutics, Inc.\DE |
Feb 2, 2023 |
1 |
-$1.84M |
4 |
Feb 3, 2023 |
Chief Executive Officer, Director |
ATXS |
Astria Therapeutics, Inc. |
Jun 9, 2022 |
1 |
$0 |
4/A |
Jun 21, 2022 |
Director |
VRDN |
Viridian Therapeutics, Inc.\DE |
Jun 1, 2022 |
1 |
-$366K |
4 |
Jun 2, 2022 |
Chief Executive Officer, Director |
VRDN |
Viridian Therapeutics, Inc.\DE |
May 2, 2022 |
1 |
-$391K |
4 |
May 4, 2022 |
Chief Executive Officer, Director |
VRDN |
Viridian Therapeutics, Inc.\DE |
Apr 1, 2022 |
2 |
-$568K |
4 |
Apr 5, 2022 |
Chief Executive Officer, Director |
VRDN |
Viridian Therapeutics, Inc.\DE |
Mar 1, 2022 |
2 |
-$529K |
4 |
Mar 3, 2022 |
Chief Executive Officer, Director |
VRDN |
Viridian Therapeutics, Inc.\DE |
Feb 1, 2022 |
4 |
-$573K |
4 |
Feb 3, 2022 |
Chief Executive Officer, Director |
VRDN |
Viridian Therapeutics, Inc.\DE |
Dec 8, 2021 |
2 |
$0 |
4 |
Dec 10, 2021 |
President and Chief Executive Officer Exhibit 24 - Power of Attorney, Director |
ATXS |
Astria Therapeutics, Inc. |
Sep 20, 2021 |
2 |
$0 |
4 |
Sep 22, 2021 |
Director |
ATXS |
CATABASIS PHARMACEUTICALS INC |
Jun 2, 2021 |
1 |
$0 |
4 |
Jun 2, 2021 |
Director |